MapLight Therapeutics Inc <MPLT.O>: BMO cuts target price to $20 from $46
MPLT•Related News
Commvault FY27 Q1 EBIT rises 8.2% to $26 million; subscription revenue climbs 16% to $267 million
CVLT•
Lantern Pharma To Advance EMA-Cleared Phase 1B/2 Trial Of Lp-184 (Zirdafulven) In Biomarker-Selected Advanced Bladder Cancer
LTRN•
Zenatech - Unit Begins Initial Flight Testing Of Interceptor P-1 Counter-Drone Platform
ZENA•
GSK-Hansoh Osteosarcoma drug succeeds in Phase III studies
GSK•
Most brokerages see Fed on hold, but hawkish view grows
SPY•